Females axSpA pts presented w/ higher disease burden (fatigue/tiredness, & spinal pain at night.) Female axSpA pts achieved sign/symptom improvement with IXE later than male axSpA pts. Abs 0934 #ACR21 #RheumNow@RheumNow https://t.co/EGXnfeF6KQ https://t.co/TDF5zxtca7
Links:
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Se…
http://ow.ly/nepC50Gt8cH
07-11-2021